ArticleBMC infectious diseases2025
Multiple detection method for SARS-CoV-2 with aptamer cocktails depending on their localization in paper-based assays.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Intrinsic Disordered N-Terminus of Nucleocapsid Protein of SARS-CoV-2 Is Critical in DNA Aptamer Binding.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe nucleocapsid (N) and spike (S) proteins are key markers for SARS-CoV-2 diagnosis and treatment because of their antigenic regions. Aptamers targeting these proteins have been developed for various diagnostic platforms, including Lateral Flow Assays (LFAs). However, existing studies have focused mainly on the use of single aptamer or antibody/aptamer sandwiches in capture zones, lacking the advantages of using aptamer cocktails. The present study aimed to develop multiple aptamer cocktail-based lateral flow assays (mACLFAs) for rapid and accurate detection of SARS-CoV-2 in clinical samples.
methodsSpherical gold nanoparticles were synthesized and used as labels for aptamer conjugation for naked-eye analysis. Aptamers specific to the S and N proteins of SARS-CoV-2 were chosen and used as either capture or detection reagents for the sandwich assay model. A nitrocellulose membrane was used to develop the mACLFAs.
resultsModel 2 was the most efficient multiple-assay model for viral diagnosis, although models 1 and 3 correctly detected the virus in clinical samples. Model 4 and Model 5 had nonspecific interactions and were not preferred for multiple assay development. The specificity of models 1, 2 and 3 was 100%, and the sensitivity of models 2 and 3 was 100%, while it was 96.6% for Model 1.
conclusionOur findings demonstrated that the accuracy of viral detection was improved by the use of aptamer cocktails, as both the N and S proteins were captured in clinical samples. The results also highlighted the importance of the position of the detector aptamers in the capture zones in terms of the accuracy and interaction of the aptamers in the sandwich assay. Thus, these findings will be valuable for developing diagnostic tools to monitor and prevent future outbreaks, such as monkey pox virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.